Abstract
ObjectiveThis study was conducted with the objective of exploring the usage of health-related quality of life (HRQOL) outcomes and willingness of health technology assessment (HTA) and public health stakeholders to use the EQ-5D-5L instrument in healthcare decision-making processes in Vietnam.MethodIn this qualitative study, 11 interviews were held with key stakeholders involved in healthcare decision-making for HTA between June 2021 and June 2022. The interviewees included members of the Vietnamese pharmacoeconomic council and public-health professionals from a diverse array of regions of Vietnam. The data collection involved obtaining verbal consent, warm-up discussions and interviews conducted via Zoom, with subsequent verification by interviewees. The analysis employed a theoretical thematic approach, adopting a deductive methodology to identify and analyse underlying ideas and meanings within the empirical data.ResultsThis study highlights the general importance and viability of HRQOL measures, and more particularly the EQ-5D-5L instrument, in healthcare decision-making in Vietnam. Challenges have been identified, including insufficient recognition, interpretation, standardisation and educational initiatives relating to HRQOL measurements. This study advocates for official training programmes on HRQOL measurements, guidelines for the application of the EQ-5D-5L and an open HRQOL database in Vietnam. Concerns regarding validity and outcome variation in HRQOL measurements underline the necessity for continuous psychometric properties assessments and regular updates to national HRQOL data in the Vietnamese context.ConclusionHRQOL outcomes are important, and Vietnamese stakeholders express a readiness to employ the EQ-5D-5L in healthcare decision-making, especially HTA. Nevertheless, HRQOL measurements, including the EQ-5D-5L, are currently inadequately used in Vietnam, and further efforts are required to improve utilisation.
Funder
Erling-Persson Foundation
Reference40 articles.
1. Maeda A , Araujo E , Cashin C , et al . Universal health coverage for inclusive and sustainable development: a synthesis of 11 country case studies . In: Directions in development, human development. Washington, DC: World Bank Group, 2014. Available: http://elibrary.worldbank.org/doi/book/10.1596/978-1-4648-0297-3
2. Drummond MF , Sculpher MJ , Claxton K , et al . Measuring and valuing efects: health gain. Methods for the economic evaluation of health care programmes. 4th edn. Oxford: Oxford University Press, 2015:123–70.
3. Fayers PM , Machin D . Quality of life. In: The assessment, analysis and interpretation of patient-reported outcomes. 2nd edn. 2007: 1–30. Available: https://onlinelibrary.wiley.com/doi/book/10.1002/9780470024522
4. An EQ-5D-5L value set for Vietnam;Mai;Qual Life Res,2020
5. Australian Government Department of H . Guidelines for preparing submissions to the pharmaceutical benefits advisory committee (PBAC). 2019.